India will get its first cervical cancer vaccine on Thursday. The vaccine is expected to make treatment easier for patients. The vaccine will be launched by the Serum Institute of India (SII) and the Ministry of Biotechnology, Government of India on September 1, 2022. On July 12, the Drug Controller General of India (DCGI) granted marketing authorization for the vaccine. - This is the first quadrivalent HPV vaccination for cervical cancer developed in India. - The Serum Institute of India will manufacture this vaccine (SII). "For the first time, a low-cost, easily accessible HPV vaccine will be made available in India to treat cervical cancer in women. We look forward to its launch later this year and thank #DCGI @MoHFW_INDIA for granting approval today," CEO Adar Poonawalla said in a July 12 Tweet. https://twitter.com/adarpoonawalla/status/1546857470571646976?t=iF9kzQgEXKs4M-pW_0XEXA&s=19 According to the

International Agency for Research on Cancer (IARC-WHO) of the World Health Organization (WHO), India sees around 1.23 cases of cervical cancer every year and nearly 67,000 women die everywhere. [video width="848" height="480" mp4="https://www.illustrateddailynews.com/wp-content/uploads/2022/09/VID-20210318-WA0004.mp4"][/video] - India ranks 5th in the world in terms of cervical cancer reporting. -The second most typical type of cancer is cervical. - According to the numbers, cervical cancer is the second leading cause of death among women aged 15 to 44. - It is usually difficult to determine its symptoms.